CASP1 and liver dysplastic nodule: Our results provide evidence galantamine impacts T2DM and DN through multiple mechanisms in the db/db mouse model including reduced food intake and weight loss, improvements in glycemic control and insulin resistance, decreasing systemic inflammation and renal apoptosis in part by modulating activity of the p38 MAPK and Caspase-1 pathways.